Abstract:Abstract Lung cancer is the leading cause of cancer-associated deaths accounting for 24% of all cancer deaths. As a crucial phase of tumor progression, lung cancer metastasis is linked to over 70% of these mortalities. In recent years, exosomes have received increasing research attention in their role in the induction of carcinogenesis and metastasis in the lung. In this review, recent studies on the contribution of exosomes to lung cancer metastasis are discussed, particularly highlighting the role of lung tumor-derived exosomes in immune system evasion, epithelial-mesenchymal transition, and angiogenesis, and their involvement at both the pre-metastatic and metastatic phases. The clinical application of exosomes as therapeutic drug carriers, their role in antitumor drug resistance, and their utility as predictive biomarkers in diagnosis and prognosis are also presented. The metastatic activity, a complex multistep process of cancer cell invasion, survival in blood vessels, attachment and subsequent colonization of the host's organs, is integrated with exosomal effects. Exosomes act as functional mediating factors in cell–cell communication, influencing various steps of the metastatic cascade. To this end, lung cancer cell-derived exosomes enhance cell proliferation, angiogenesis, and metastasis, regulate drug resistance, and antitumor immune activities during lung carcinogenesis, and are currently being explored as an important component in liquid biopsy assessment for diagnosing lung cancer. These nano-sized extracellular vesicles are also being explored as delivery vehicles for therapeutic molecules owing to their unique properties of biocompatibility, circulatory stability, decreased toxicity, and tumor specificity. The current knowledge of the role of exosomes highlights an array of exosome-dependent pathways and cargoes that are ripe for exploiting therapeutic targets to treat lung cancer metastasis, and for predictive value assessment in diagnosis, prognosis, and anti-tumor drug resistance.

Enigmatic exosomal connection in lung cancer drug resistance

Exosome: Emerging Biomarker in Breast Cancer

Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance

Exosome Mediated Multidrug Resistance in Cancer.

Exosomes: A New Pathway for Cancer Drug Resistance

Role of exosomal microRNAs in lung cancer biology and clinical applications

The Biological Functions and Clinical Applications of Exosomes in Lung Cancer

Exosomal Long Non-Coding RNAs: Biological Properties and Therapeutic Potential in Cancer Treatment

Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance

Exosome: Function and Role in Cancer Metastasis and Drug Resistance

Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities

The role of exosomes in lung cancer metastasis and clinical applications: an updated review

Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis

Extracellular Vesicles and Exosomes: Novel Insights and Perspectives on Lung Cancer from Early Detection to Targeted Treatment

Tumor‐derived exosomes: Key players in non‐small cell lung cancer metastasis and their implication for targeted therapy

Exosomal microRNAs in lung cancer: a narrative review

Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications

Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance

Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers

Lung cancer cell-derived exosomes: progress on pivotal role and its application in diagnostic and therapeutic potential

Extracellular vesicles in anti-tumor drug resistance: Mechanisms and therapeutic prospects